MapLight Therapeutics, Inc.

MPLT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
Assets
Cash & Equivalents$38$80$28
Short-Term Investments$71$0$0
Receivables$0$0$0
Inventory$0$0$0
Other Curr. Assets$6$4$4
Total Curr. Assets$115$84$32
Property Plant & Equip (Net)$8$7$7
Goodwill$0$0$0
Intangibles$0$0$0
Long-Term Investments$12$1$0
Tax Assets$0$0$0
Other NC Assets$3$0$0
Total NC Assets$22$8$7
Other Assets$0$0$0
Total Assets$137$91$39
Liabilities
Payables$0$0$0
Short-Term Debt$1$0$0
Tax Payable$0$0$0
Deferred Revenue$3$4$6
Other Curr. Liab.$12$10$6
Total Curr. Liab.$16$15$13
LT Debt$6$5$6
Deferred Rev, NC$0$0$0
Deferred Tax Liab, NC$0$0$0
Other NC Liab.$0$0$0
Total NC Liab.$6$5$6
Other Liabilities$0$0$0
Cap. Leases$6$5$6
Total Liabilities$22$20$19
Equity
Pref Stock$309$189$84
Common Stock$0$0$0
Retained Earnings-$199-$122-$66
AOCI$0$0$0
Other Equity$6$4$3
Total Equity$115$71$21
Supplemental Information
Minority Interest$0$0$0
Total Liab. & Tot. Equity$137$91$39
Net Debt-$32-$74-$21
MapLight Therapeutics, Inc. (MPLT) Financial Statements & Key Stats | AlphaPilot